| Name | Title | Contact Details |
|---|
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.
Gillette Children's Specialty Health is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Gillette Children's Specialty Health is based in Saint Paul, MN. You can find more information on Gillette Children's Specialty Health at www.gillettechildrens.com
Bayer MaterialScience is the global market leader in polyurethanes. The company develops and produces the components for rigid and flexible foams as well as for solid materials. Diverse applications range from mattresses and ski boots to insulating materials for refrigeration appliances and buildings. Bayer MaterialScience is also the leader in the development and production of polycarbonates. Lightweight, tough and freely formable, these high-performance plastics can be used in a wide variety of applications, including in the automotive and construction industries. Bayer MaterialScience is also one of the world’s leading suppliers of raw materials for coatings, adhesives and sealants. These products protect and enhance the appearance of such things as automobiles and furniture, and are used in the sports and leisure sector. In addition, Bayer MaterialScience supplies the chemical industry with numerous basic chemicals.
Cavapharma is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.